Immune pathogenesis of paroxysmal nocturnal hemoglobinuriaTIU, Ramon; MACIEJEWSKI, Jaroslaw.International journal of hematology. 2006, Vol 84, Num 2, pp 113-117, issn 0925-5710, 5 p.Article

Blood consult: treating del(5q) myelodysplastic syndromesMUKHERJEE, Sudipto; TIU, Ramon V; SEKERES, Mikkael A et al.Blood. 2012, Vol 119, Num 2, pp 342-344, issn 0006-4971, 3 p.Article

Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignanciesMACIEJEWSKI, Jaroslaw P; TIU, Ramon V; O'KEEFE, Christine et al.British journal of haematology. 2009, Vol 146, Num 5, pp 479-488, issn 0007-1048, 10 p.Article

Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhageKALMADI, Sujith; TIU, Ramon; LOWE, Christopher et al.Cancer. 2006, Vol 107, Num 1, pp 136-140, issn 0008-543X, 5 p.Article

Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine TherapyMAHFOUZ, Reda Z; JANKOWSKA, Ania; ENGELKE, Kory J et al.Clinical cancer research (Print). 2013, Vol 19, Num 4, pp 938-948, issn 1078-0432, 11 p.Article

De Novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clonePORTELL, Craig A; SEKERES, Mikkael A; ROGERS, Heesun J et al.British journal of haematology. 2012, Vol 157, Num 2, pp 266-267, issn 0007-1048, 2 p.Article

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. CommentarySUAREZ-SAIZ, Fernando; MINDEN, Mark D; GONDEK, Lukasz P et al.Blood. 2008, Vol 111, Num 3, issn 0006-4971, 977-978, 1534-1542 [11 p.]Article

p53-Independent, Normal Stem Cell Sparing Epigenetic Differentiation Therapy for Myeloid and Other Malignancies : MOLECULAR PATHOGENESIS OF HEMATOLOGIC MALIGNANCIESSAUNTHARARAJAH, Yogen; TRIOZZI, Pierre; COPELAN, Ed et al.Seminars in oncology. 2012, Vol 39, Num 1, pp 97-108, issn 0093-7754, 12 p.Article

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutationSZPURKA, Hadrian; TIU, Ramon; MURUGESAN, Gurunathan et al.Blood. 2006, Vol 108, Num 7, pp 2173-2181, issn 0006-4971, 9 p.Article

Tumor lysis syndromeTIU, Ramon V; MOUNTANTONAKIS, Stavros E; DUNBAR, Andrew J et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 4, pp 397-407, issn 0094-6176, 11 p.Article

Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutterMOUNTANTONAKIS, Stavros E; MOUTZOURIS, Dimitrios A; TIU, Ramon V et al.The American journal of emergency medicine. 2006, Vol 24, Num 4, pp 407-412, issn 0735-6757, 6 p.Article

Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemiaAFABLE, Manuel G; SHAIK, Mohammed; TIU, Ramon V et al.Haematologica (Roma). 2011, Vol 96, Num 9, pp 1269-1275, issn 0390-6078, 7 p.Article

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasmsJANKOWSKA, Anna M; SZPURKA, Hadrian; TIU, Ramon V et al.Blood. 2009, Vol 113, Num 25, pp 6403-6410, issn 0006-4971, 8 p.Article

A Phase 2 Trial of Combination Therapy With Thalidomide, Arsenic Trioxide, Dexamethasone, and Ascorbic Acid (TADA) in Patients With Overlap Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) or Primary Myelofibrosis (PMF)BEJANYAN, Nelli; TIU, Ramon V; SEKERES, Mikkael A et al.Cancer. 2012, Vol 118, Num 16, pp 3968-3976, issn 0008-543X, 9 p.Article

SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromesAFABLE, Manuel G; WLODARSKI, Marcin; MAKISHIMA, Hideki et al.Blood. 2011, Vol 117, Num 25, pp 6876-6884, issn 0006-4971, 9 p.Article

Risk for Developing Myelodysplastic Syndromes in Prostate Cancer Patients Definitively Treated With RadiationMUKHERJEE, Sudipto; REDDY, Chandana A; MACIEJEWSKI, Jaroslaw P et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 3, issn 0027-8874, 1.1-1.12Article

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesisMAKISHIMA, Hideki; VISCONTE, Valeria; SEKERES, Mikkael A et al.Blood. 2012, Vol 119, Num 14, pp 3203-3210, issn 0006-4971, 8 p.Article

Topography, Clinical, and Genomic Correlates of 5q Myeloid Malignancies RevisitedJEREZ, Andres; GONDEK, Lukasz P; MCDEVITT, Michael A et al.Journal of clinical oncology. 2012, Vol 30, Num 12, pp 1343-1349, issn 0732-183X, 7 p.Article

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3AJANKOWSKA, Anna M; MAKISHIMA, Hideki; HSI, Eric D et al.Blood. 2011, Vol 118, Num 14, pp 3932-3941, issn 0006-4971, 10 p.Article

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromesSEKERES, Mikkael A; TIU, Ramon V; TABARROKI, Ali et al.Blood. 2012, Vol 120, Num 25, pp 4945-4951, issn 0006-4971, 7 p.Article

New Lesions Detected by Single Nucleotide Polymorphism Array-Based Chromosomal Analysis Have Important Clinical Impact in Acute Myeloid LeukemiaTIU, Ramon V; GONDEK, Lukasz P; ADVANI, Anjali S et al.Journal of clinical oncology. 2009, Vol 27, Num 31, pp 5219-5226, issn 0732-183X, 8 p.Conference Paper

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesisJEREZ, Andres; SUGIMOTO, Yuka; KULASEKARARAJ, Austin G et al.Blood. 2012, Vol 119, Num 25, pp 6109-6117, issn 0006-4971, 9 p.Article

SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromesVISCONTE, Valeria; ROGERS, Heesun J; JEREZ, Andres et al.Blood. 2012, Vol 120, Num 16, pp 3173-3186, issn 0006-4971, 14 p.Article